CASI PHARMACEUTICALS, INC. (CASIF) Capital expenditures 2020–2025
CASI PHARMACEUTICALS, INC. (CASIF) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$16,000FY2025 · since FY2020: $1.5M → $16,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $16,000 | -92.8% |
| FY2024 | $223,000 | +9.3% |
| FY2023 | $204,000 | -96.4% |
| FY2022 | $5.6M | -37.3% |
| FY2021 | $8.9M | +496.7% |
| FY2020 | $1.5M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice
More CASIF financial trends
CASIF RevenueCASIF Net incomeCASIF Net marginCASIF Gross profitCASIF Gross marginCASIF Operating incomeCASIF Operating marginCASIF Operating cash flowCASIF Free cash flowCASIF Return on equityCASIF Stock buybacksCASIF Dividends paidCASIF Total assetsCASIF Total liabilitiesCASIF Shareholders’ equityCASIF overview →